SEVRE-LONG caps ret 30 mg 30 pce
7680539520113
CH-53952
N02AA01
01.01.3.
Reimbursement limitations:
SEVRE-LONG
Douleurs prolongées modérées à sévères ou en cas d’efficacité insuffisante des analgésiques non-opioïdes et/ou des …
1 / 3
google
Details
- Product number
- 5395201
- CPT
- -
- Packaging group
- 30
- Unit
- Kapsel(n)
- Composition
- morphini sulfas pentahydricus 30 mg corresp. morphinum 22.56 mg, oleum vegetabile hydrogenatum, macrogolum 6000, talcum, magnesii stearas, Kapselhülle: E 132, E 171, natrii laurilsulfas corresp. natrium 0.006 mg, gelatina, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, pro capsula.
Articles (1)
Sevre-Long 30 mg, Kapseln retard
Kapseln
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
30.0 MG | Substance | WIZUS |
|
(N/A)
|
22.56 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
0.006 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
Reimbursement information
Public price
CHF 38.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2002
Authorization holder
Mundipharma Medical Company,
4052 Basel
Authorization information
- Swissmedic authorization number
- 53952
- Drug name
- Sevre-Long, Kapseln retard
- Galenic form
- RETH
- ATC Code
- N02AA01
- Authorization status
- Z
- Dispensation category
- A+
- First authorization
- 30/01/1997
- Authorization expiration date
- 31/12/9999
- IT number
- 01.01.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SEVRE-LONG caps ret 30 mg 30 pce
- Description (DE)
- SEVRE-LONG Ret Kaps 30 mg 30 Stk
- Market launch
- 30/01/1997
- Narcotic (BTM)
- A